<DOC>
	<DOCNO>NCT02077140</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety MDT-10013 men woman 18 80 year age undergoing bunionectomy . The primary objective determine analgesic efficacy MDT-10013 compare standard care treatment acute postoperative pain subject undergo bunionectomy .</brief_summary>
	<brief_title>A Study MDT-10013 Treatment Acute Postoperative Pain Following Bunionectomy</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<criteria>1 . Is male female age 18 80 year . 2 . Has body mass index 18 kg/m2 40 kg/m2 . 3 . Is schedule undergo primary , unilateral , first metatarsal bunionectomy ( osteotomy internal fixation ) additional collateral procedure . 4 . Is classified American Society Anesthesiologists Physical Status Classification System Class I II . 5 . Must meet follow criterion female : Is nonchildbearing potential , defined woman undergone surgical sterilization 2 year postmenopausal If childbearing potential , may enrol condition result pregnancy test negative baseline ( Screening surgery ) routinely use effective method birth control low failure rate ( i.e. , hormonal contraception , intrauterine device , condom combination spermicidal cream , total sexual abstinence ) 6 . Has read , understood , sign informed consent prior study entry . 7 . Is mentally competent , reliable , cooperative undergo visit procedure schedule study protocol record require information . 8 . Has medical history , physical examination , vital sign , laboratory test , 12lead electrocardiogram ( ECGs ) normal without clinically relevant abnormality per investigator 's judgment . 1 . Is female pregnant breastfeeding . 2 . Is indicated surgery inflammatory process risk infection delay wound heal ( e.g. , autoimmune disorder ) . 3 . Has history allergy hypersensitivity component investigational product opioid medication ( oxycodone ) . 4 . Before surgery , current orthostatic hypotension ( define systolic blood pressure decrease least 20 mm Hg diastolic blood pressure decrease least 10 mm Hg increase heart rate 20 beat per minute within 3 minute sit stand ) . 5 . Has severe asthma , define require frequent ongoing treatment control symptom . Exerciseinduced asthma mild asthma require ongoing treatment may exclusionary discretion investigator . 6 . Has current gastrointestinal disorder associate bleeding , history disorder , gastrointestinal inflammatory diseases Crohn 's disease ulcerative colitis . 7 . Has clinically significant cardiovascular condition evidence physical examination , medical history , and/or baseline ECG . 8 . Has evidence bradycardia show heart rate &lt; 50 beat per minute via screen ECG . 9 . Has know infection human immunodeficiency virus , hepatitis B virus , hepatitis C virus . 10 . Has chronic pain condition may interfere subject 's assessment pain postoperatively , determine investigator . 11 . Has poorly control serious medical condition , psychiatric illness , clinically significant laboratory value , opinion investigator , could compromise safety subject scientific integrity study ( e.g. , uncontrolled hypertension , autoimmune disease , clinically relevant symptom thyroid dysfunction ) . 12 . Has presence history local systemic malignant disease past 5 year ( history basal cell carcinoma allow ) . 13 . Has impair renal function ( creatinine &gt; 1.5 time upper limit normal ) . 14 . Has chronic impairment liver function ( aspartate aminotransferase alanine aminotransferase &gt; 3 time upper limit normal ) . 15 . Has insulindependent diabetes uncontrolled diabetes mellitus ( glycosylated hemoglobin &gt; 7 % ) . 16 . Has leukopenia ( &lt; 3500 leukocytes/Î¼L ) . 17 . Has current treatment follow medication : 1 . Systemic corticosteroid ( intranasal/inhaled steroid acceptable ) . 2 . Immunosuppressant therapy treat autoimmune disease ( e.g. , rheumatoid arthritis , multiple sclerosis , myasthenia gravis , systemic lupus erythematosus , sarcoidosis , focal segmental glomerulosclerosis , Crohn 's disease , Behcet 's Disease , pemphigus , ulcerative colitis ) . 3 . Oral topical product contain clonidine ( e.g. , Catapres ) . 4 . Herbal supplement contain yohimbine . 5 . Anticoagulant/antiplatelet therapy ( prophylactic aspirin 81 mg/day acceptable ) . If applicable , aspirin therapy hold study procedure basis investigator 's discretion . 6 . Antiepileptic drug , antipsychotic , tricyclic antidepressant , monoamine oxidase inhibitor , lithium , sulfonamide . 7 . Calcium channel blocker , digoxin , betaadrenergic blocker . 18 . Has chronic use opioids ( include tramadol ) , define use 20 last 30 day study screen . 19 . Has history current diagnosis epilepsy . 20 . Has know suspected history drug alcohol abuse ( determine investigator ) . 21 . Is judged investigator suitable candidate study treatment pain relief medication basis medical history , concomitant medication , concurrent systemic disease . 22 . Is stabilize follow medication least 8 week prior dose : selective serotonin reuptake inhibitor ( SSRIs ) serotoninnorepinephrine reuptake inhibitor ( SNRIs ) . 23 . Is unable refrain take nonsteroidal anti inflammatory drug ( NSAIDs ) opioids within 24hour period prior surgery . 24 . Has participate clinical trial 4 week prior Screening . 25 . Experiences surgical complication , opinion investigator , preclude implantation MDT10013 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>